TBG Diagnostics Debt 2024

TBG Diagnostics Aktienanalyse

What does TBG Diagnostics do?

TBG Diagnostics Ltd is an Australian company specializing in the manufacturing and marketing of in vitro diagnostic products. The company was originally founded in 2009 under the name TBG Biotechnology Pty Ltd and later became a corporation. The company's business model is to provide fast and reliable diagnostic solutions for various disease conditions. The company operates in various areas, including infectious diseases, diarrheal diseases, tumor diagnostics, cardiovascular diseases, and oncology. In the infectious diseases field, for example, TBG Diagnostics offers test kits for the diagnosis of HIV, hepatitis, dengue fever, and other infectious diseases. The test kits consist of immunological rapid tests that typically provide results within 15-20 minutes, allowing doctors to quickly make a diagnosis and initiate appropriate therapy. In the diarrheal diseases field, the company has developed a special test kit that allows for the detection of rotaviruses. Rotavirus infections are one of the most common causes of severe diarrhea in infants and can lead to serious complications if left untreated. TBG Diagnostics' tumor diagnostics division offers specialized test kits for the diagnosis of prostate cancer, breast cancer, and colorectal cancer. The test kits are based on the measurement of tumor markers in the blood and are a fast and non-invasive method for early cancer detection. The company's cardiovascular division offers test kits for the diagnosis of thyroid hormones and troponin. Troponin is a protein complex that is released into the blood in increased amounts when there is damage to the heart muscle and can be an indication of a heart attack. In collaboration with partners, TBG Diagnostics also develops innovative solutions for oncology. One example is a special test kit that enables personalized medicine for patients with advanced bladder cancer. The test kit analyzes the DNA of tumor cells and allows doctors to find individually tailored therapies for the patient. TBG Diagnostics is a successful company that has experienced steady growth in recent years. The company is listed on the Australian stock exchange and has a strong international distribution network, enabling it to distribute its products worldwide. Overall, TBG Diagnostics is a company specializing in the development and manufacturing of innovative diagnostic products. By focusing on various areas and collaborating with partners, the company can quickly respond to changing requirements in healthcare and offer customized solutions to its customers. TBG Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding TBG Diagnostics's Debt Structure

TBG Diagnostics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing TBG Diagnostics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to TBG Diagnostics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in TBG Diagnostics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about TBG Diagnostics stock

What is the debt of TBG Diagnostics this year?

TBG Diagnostics has a debt level of 0 AUD this year.

What was the debt of TBG Diagnostics compared to the previous year?

The debt of TBG Diagnostics has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in TBG Diagnostics?

High debt can pose a risk for investors of TBG Diagnostics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of TBG Diagnostics?

Low debt means that TBG Diagnostics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from TBG Diagnostics affect the company?

An increase in debt of TBG Diagnostics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of TBG Diagnostics affect the company?

A reduction in debt of TBG Diagnostics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of TBG Diagnostics?

Some factors that can influence the debt of TBG Diagnostics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of TBG Diagnostics so important for investors?

The debts of TBG Diagnostics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can TBG Diagnostics take to change the debt?

To change the debt, TBG Diagnostics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does TBG Diagnostics pay?

Over the past 12 months, TBG Diagnostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, TBG Diagnostics is expected to pay a dividend of 0 AUD.

What is the dividend yield of TBG Diagnostics?

The current dividend yield of TBG Diagnostics is .

When does TBG Diagnostics pay dividends?

TBG Diagnostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of TBG Diagnostics?

TBG Diagnostics paid dividends every year for the past 0 years.

What is the dividend of TBG Diagnostics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is TBG Diagnostics located?

TBG Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von TBG Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of TBG Diagnostics from 11/14/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/14/2024.

When did TBG Diagnostics pay the last dividend?

The last dividend was paid out on 11/14/2024.

What was the dividend of TBG Diagnostics in the year 2023?

In the year 2023, TBG Diagnostics distributed 0 AUD as dividends.

In which currency does TBG Diagnostics pay out the dividend?

The dividends of TBG Diagnostics are distributed in AUD.